三叉神经痛微血管减压术患者的术前阿片类药物使用与术后结局
本研究回顾性分析了2007至2020年间本机构920例接受微血管减压术的三叉神经痛患者,其中145例(15.8%)术前使用阿片类药物。术前使用阿片类药物与术后末次随访疼痛评分更高、疼痛复发风险增加独立相关。
要点
- 术前使用阿片类药物的三叉神经痛患者术后疼痛结局更差。
- 术前阿片类药物使用是术后末次随访疼痛评分更高的独立危险因素。
- 术前阿片类药物使用与疼痛复发风险增加相关。
核心结论
- 三叉神经痛患者术前使用阿片类药物与微血管减压术后更差的疼痛结局和增加的疼痛复发风险相关。
- 这些结果提示对三叉神经痛应谨慎处方阿片类药物,术前使用阿片类药物的患者微血管减压术后结局可能更差。
研究设计与样本
- 回顾性研究,纳入本机构2007年至2020年间接受微血管减压术的三叉神经痛患者920例。
- 根据术前阿片类药物使用情况将患者分为2组,比较人口学信息、合并症、三叉神经痛特征、术前用药、疼痛和麻木结局及复发数据。
- 采用多因素有序回归、Kaplan-Meier生存分析和Cox比例风险模型评估组间疼痛结局差异。
主要发现
- 145例(15.8%)患者术前使用阿片类药物。
- 术前使用阿片类药物的患者更年轻(P = .04),更可能有吸烟史(P < .001),末次随访时改良Barrow神经病学研究所疼痛评分更高(P = .001),更可能经历疼痛复发(P = .01)。
- 术前使用阿片类药物的患者更可能术前同时处方肌肉松弛剂和抗抑郁药等三叉神经痛药物(P < .001和P < .001)。
- 多因素回归控制女性性别和年龄等变量后,阿片类药物使用是末次随访时术后疼痛更严重的独立危险因素(P = .006)。
- Kaplan-Meier分析显示阿片类药物使用与更短的疼痛复发时间相关(P = .005),Cox比例风险回归显示与复发风险增加相关(P = .008)。
临床怎么用
- 作者认为,这些结果提示对三叉神经痛应谨慎处方阿片类药物,术前使用阿片类药物的患者微血管减压术后结局可能更差。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The prescription of opioid analgesics for trigeminal neuralgia (TN) is controversial, and their effect on postoperative outcomes for patients with TN undergoing microvascular decompression (MVD) has not been reported. We aimed to describe the relationship between preoperative opioid use and postoperative outcomes in patients with TN undergoing MVD. METHODS: We reviewed the records of 920 patients with TN at our institution who underwent an MVD between 2007 and 2020. Patients were sorted into 2 groups based on preoperative opioid usage. Demographic information, comorbidities, characteristics of TN, preoperative medications, pain and numbness outcomes, and recurrence data were recorded and compared between groups. Multivariate ordinal regression, Kaplan-Meier survival analysis, and Cox proportional hazards were used to assess differences in pain outcomes between groups. RESULTS: One hundred and forty-five (15.8%) patients in this study used opioids preoperatively. Patients who used opioids preoperatively were younger ( P = .04), were more likely to have a smoking history ( P < .001), experienced greater pain in modified Barrow Neurological Institute pain score at final follow-up ( P = .001), and were more likely to experience pain recurrence ( P = .01). In addition, patients who used opioids preoperatively were more likely to also have been prescribed TN medications including muscle relaxants and antidepressants preoperatively ( P < .001 and P < .001, respectively). On multivariate regression, opioid use was an independent risk factor for greater postoperative pain at final follow-up ( P = .006) after controlling for variables including female sex and age. Opioid use was associated with shorter time to pain recurrence on Kaplan-Meier analysis ( P = .005) and was associated with increased risk for recurrence on Cox proportional hazards regression ( P = .008). CONCLUSION: Preoperative opioid use in the setting of TN is associated with worse pain outcomes and increased risk for pain recurrence after MVD. These results indicate that opioids should be prescribed cautiously for TN and that worse post-MVD outcomes may occur in patients using opioids preoperatively.
引用
- Kalluri AL, Ejimogu E, Kilgore C, et al. Preoperative Opioid Use and Postoperative Outcomes in Patients Undergoing Microvascular Decompression for Trigeminal Neuralgia. Neurosurgery. 2024. PMID: 38483172. doi:10.1227/neu.0000000000002904
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。